Pancreatic adenocarcinoma (PAC) is associated with extremely poor prognosis and remains
a lethal malignancy. The main cure for PAC is surgical resection. Further treatment …

Pancreatic cancer is an extremely malignant tumor with the lowest 5-year survival rate
among all tumors. Pancreatic ductal adenocarcinoma (PDAC), as the most common …

Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆ -
Annals of Oncology Skip to Main Content Advertisement Annals of Oncology European Society …

Background Neoantigens are critical targets to elicit robust antitumor T-cell responses.
Personalized cancer vaccines developed based on neoantigens have shown promising …

Abstract Cancer-associated fibroblasts (CAFs), are the key effector cells in pancreatic ductal
adenocarcinoma (PDAC), known to induce tumor growth and progression. Pancreatic …

Pancreatic cancer is one of the most lethal malignancies. Significant progresses have been
made in understanding of pancreatic cancer pathogenesis, including appreciation of …

Laparoscopic surgery for benign and malignant pancreatic lesions has slowly been gaining
acceptance over the past decade and is being introduced in many centres. Some studies …

Pancreatic adenocarcinoma (PAAD) is one of the most leading causes of cancer-related
death across the world with the limited efficiency and response rate of immunotherapy …

The utility of KRAS mutations in plasma circulating cell-free DNA (cfDNA) samples as non-
invasive biomarkers for the detection of pancreatic cancer has never been evaluated in a …

Autophagy is an important bioprocess throughout the occurrence and development of
cancer. However, the role of autophagy-related lncRNAs in pancreatic cancer (PC) remains …